The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients
Clinical trial NCT03193086 · UNKNOWN
Trial details
- NCT number
- NCT03193086
- Sponsor
- Glostrup University Hospital, Copenhagen
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-03-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.